FY2027 Q1
13 Aug 2026
-
First question is I mean we've got a revenue decline of 8.5% year-on-year and 5.5% Quarter-on- Quarter roughly. Could you give us the mix between the volume and pricing?
Read in transcript -
Okay. 4% improvement in price. And sir, what is our product strategy because over the years, we've seen somewhere or the other one molecule which was probably a rock star for us in the previous year ends up not doing well in the next year. So, I guess we are getting impacted due to the number of products which probably are our star molecules.
Read in transcript -
Sir, how many products do we plan to add this year and next year?
Read in transcript